A CME/CNE Regional Dinner Program Series: New Molecular Targets and Novel Agents for the Treatment of Advanced Renal Cell Carcinoma: From Rational Design to Clinical Efficacy

The CBCE
Ultima Vez Modificado: 21 de noviembre del 2007

Share article


English

Conference Dates: January 14-30, 2008
Conference Location: Nationwide

Sponsoring Group: The CBCE

Conference Web Page URL: http://www.thecbce.com/rcc

Topics Covered: This interactive dinner discussion/presentation forum, including key abstracts presented at the 43rd American Society of Clinical Oncology Annual Meeting, will utilize multiple methods of participation to engage attendees and enhance the learning process.

Conference Objectives: After participating in this educational activity, attendees should be able to:

  1. Describe the aberrant signaling pathways characteristic of RCC.
  2. Discuss the safety and efficacy of recently approved novel multitargeted agents for RCC.
  3. Discuss recent clinical trials investigating the safety and efficacy of MoAbs in the treatment of RCC.
  4. Describe recent clinical trials investigating the safety and efficacy of novel agents targeting single pathways for the treatment of RCC.

Who Should Attend: This activity is designed for oncologists, physicians, nurses, and other health care professionals interested in recent advances in the treatment of patients with renal cell carcinoma.

Registration Information: For further information, please contact the CBCE, 1707 Market Place Blvd., Suite 370, Irving, Texas 75063; Telephone: (214) 260-9024; Fax: (214) 260-0509; E-mail: info@thecbce.com.

Continuing Education: Yes

English
News
AACR: Novel Breast Cancer Therapy Exploits Autophagy Response

Aug 22, 2014 - Targeting a cancer cell's heat shock response protein 70 with panobinostat to induce autophagy in the stressed cell, and then introducing an autophagy inhibitor to force the cell to die off, may be an effective novel treatment strategy for breast cancer, according to a Nov. 16 press briefing presented at the American Association for Cancer Research -- National Cancer Institute -- European Organisation for Research and Treatment of Cancer International Conference, "Molecular Targets and Cancer Therapeutics," held from Nov. 15 to 19 in Boston.



I Wish You Knew

How cancer patients have changed my life

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Frente a un nuevo diagnóstico de cáncer o de cambiar el curso de su tratamiento actual? Deje que nuestro personal de enfermería cáncer que ayudan a pasar!

Más información